NeuroBo Pharmaceuticals Receives IRB Approval for Phase 1 Clinical Trial of DA1726 A Potential Treatment for Obesity
NeuroBo Pharmaceuticals has recently obtained the initial site Institutional Review Board (IRB) approval for its Phase 1 clinical trial assessing ...